6 results
Selected Clinical Trials of SGLT2 inhibitors in CVD and CKD
EMPA-REG OUTCOME - Empagliflozin lowered CV events
inhibitors in CVD ... HF outcomes in HFrEF ... on GDMT, with or ... HF outcomes in HFrEF ... SGLT2 #inhibitors #EBM
Algorithm for screening/diagnosis and treatment/follow‐up of iron deficiency in patients with chronic heart failure. Hb, haemoglobin;
/follow‐up of iron ... , haemoglobin; HFrEF ... Management #Diagnosis #HFrEF ... HeartFailure #Cardiology #Indications ... #Treatment
Diagnostic Algorithm for Treatment of Iron Deficiency in Patients With Heart Failure 

Consensus Recommendations 

#Iron #Deficiency
Algorithm for Treatment ... of Iron Deficiency ... Diagnosis #Algorithm #HFrEF ... #HeartFailure #Indications ... #Treatment
Guideline-Directed Medical Therapy (GDMT) in HFrEF and CKD

 • Class I pillars of HFrEF GDMT across
) in HFrEF and CKD ... Class I pillars of HFrEF ... therapies" for HFrEF ... used in HFrEF: ... #CKD #HFrEF #management
Heart Failure (HFrEF) Treatment - GDMT for stage C 

For patients with Heart Failure with REDUCED
Heart Failure (HFrEF ... ) Treatment - GDMT ... Ejection Fraction (HFrEF ... patients with HFrEF ... #HeartFailure #HFrEF
Iron Deficiency in Heart Failure
Pathophysiology:
Chronic heart failure leads to an increase in inflammatory cytokines → Inflammation
Iron Deficiency ... absorption and iron ... functional ID) Treatment ... mortality and CV ... deficiency #CHF #HFrEF